Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE
dc.contributor.author | Haran, A. M. | |
dc.contributor.author | Jain, Y. | |
dc.contributor.author | Hambrock, T. | |
dc.contributor.author | Murphy, L. R. | |
dc.contributor.author | Cook, A. | |
dc.contributor.author | Brown, L. C. | |
dc.contributor.author | Hoyle, Alex P | |
dc.contributor.author | Sachdeva, Ashwin | |
dc.contributor.author | Ali, S. A. | |
dc.contributor.author | Amos, C. L. | |
dc.contributor.author | Sydes, M. R. | |
dc.contributor.author | Attard, G. | |
dc.contributor.author | Parmar, M. K. | |
dc.contributor.author | James, N. D. | |
dc.contributor.author | Clarke, Noel W | |
dc.date.accessioned | 2023-01-24T10:32:25Z | |
dc.date.available | 2023-01-24T10:32:25Z | |
dc.date.issued | 2022 | en |
dc.identifier.citation | Haran AM, Jain Y, Hambrock T, Murphy LR, Cook A, Brown LC, et al. Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE. Annals of Oncology. 2022 Sep;33(7):S1161-S2. PubMed PMID: WOS:000866211601616. | en |
dc.identifier.doi | 10.1016/j.annonc.2022.07.1946 | en |
dc.identifier.uri | http://hdl.handle.net/10541/625974 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.annonc.2022.07.1946 | en |
dc.title | Differential treatment response with nodal metastases in metastatic hormone-sensitive prostate cancer (mHSPC) and evaluation of nodal (N) burden as a prognostic biomarker: Ancillary studies of the docetaxel and abiraterone acetate and prednisolone (AAP) phase III trials from STAMPEDE | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Genito-Urinary Cancer Research Group, The University of Manchester, Manchester,UK | en |
dc.identifier.journal | Annals of Oncology | en |
dc.description.note | en] |